Publications:211
- Mount Sinai Doctors
Noam Harpaz, MD
Anatomic Pathology and Clinical Pathology
No Patient Experience Ratings
About Me
Clinical Interest
Gastrointestinal pathology, general surgical pathology, and diagnostic immunopathology.
Language
English
Position
PROFESSOR | Pathology, Molecular and Cell Based Medicine, PROFESSOR | Medicine, Gastroenterology
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Clinical Focus
- Anal Cancer
- Barrett's Esophagus
- Celiac Disease
- Colon Polyps
- Colorectal Cancer
- Colorectal Resection
- Crohn's Disease
- Diverticulitis
- Esophageal Cancer
- Esophagectomy
- Gastrectomy
- Gastritis
- Inflammatory Bowel Disease
- Ischemic Bowel Disease
- Peptic Ulcer
- Small Bowel Resection
- Stomach Cancer
- Ulcerative Colitis
- Upper GI Endoscopy
Education
PhD, Feinberg Graduate School Weizmann Institute of Science
, Hospital for Sick Children
MD, University of Miami School of Medicine
MD, University of Miami School of Medicine
, Mount Sinai School of Medicine
, St. Mark's Hospital
Residency, Pathology
Mount Sinai Hospital
Certifications
American Board of Pathology
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Histologic and combined histologic–endoscopic outcomes with mirikizumab in Crohn’s disease: VIVID-1 trial results. Vipul Jairath, Fernando Magro, Marijana Protic, Gert De Hertogh, Noam Harpaz, Tadakazu Hisamatsu, Geert D’Haens, Rish Pai, Guanglei Yu, Nathan Morris, Wen Tao Luo, Emily Hon, Rodrigo Escobar, Luc Biedermann, Walter Reinisch, Emiliano Tron, Fernanda Dorado Dorado, Lena Thin, Rupert Leong, Hans Seltenreich, Britt Christensen, Anthony Croft, Simon Ghaly, Robert Koch, Walter Reinisch, Sonja Heeren, Peter Bossuyt, Marc Ferrante, Fabio Luiz Maximiano, Ligia Yukie Sassaki, Carolina Baia, Debora Poli, Alexandre de Sousa Carlos, Carlos Fernando de Magalhaes Francesconi, Alexander De Sa Rolim, Julio Razera, Joaquim Simoes Neto, Rodrigo Rocco, Jonathas Stifft, Jonathan Soldera, Genoile Silva, Cintia Mendes Clemente, Sandra Di Felice Boratto, Luciana Teixeira de Campos, Marcelo Rodrigues Borba, Gregory Rosenfeld, Terry Ponich, Allen Lim, Chadwick Williams, Bruce Musgrave. Journal of Crohn's and Colitis
- Histopathologic Evaluation and Reporting in Inflammatory Bowel Disease: A Consensus Document Sponsored by the Rodger C. Haggitt Gastrointestinal Pathology Society. Alexandros D. Polydorides, Xiuli Liu, Shaomin Hu, Michael G. Drage, Jean Frederic Colombel, Dermot P.B. McGovern, Gert De Hertogh, Vikram Deshpande, Michael Vieth, Mary P. Bronner, Roger Feakins, Noam Harpaz, John Hart, John R. Goldblum, Joel K. Greenson, Gregory Y. Lauwers, Iris D. Nagtegaal, Robert D. Odze, Rish K. Pai, Robert Riddell, Bo Shen, Neil A. Shepherd, Magali Svrcek, Rhonda K. Yantiss, Nicole C. Panarelli. Modern Pathology
- Pancolonic mast cell elevation correlates with IBS-like symptoms in ulcerative colitis patients achieving combined endoscopic and histologic remission: a retrospective case–control study. Michael Christian Virata, Thomas Vincent Wong, Noam Harpaz. Human Pathology Reports
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Harpaz during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services
Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership- Martin Clearwater and Bell
- Emery Celli Brinckerhoff Abady Ward & Maazel Llp
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.